MapLight Therapeutics Overview
MapLight Therapeutics Target Price
Analysts' 12-month price predictions for MPLT.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.09
Average Target Price
$43.00
15.9% upside
15.9% upside6 analysts in the last 4 months
High: $48 | Low: $36
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-24 | Raymond James | $46 | 24% upside |  |
| 2026-06-23 | Craig-Hallum | $40 | 7.8% upside | |
| 2026-06-01 | Stifel NicolausPaul Matteis | $36 |  2.9% downside | |
| 2026-05-26 | UBSAshwani Verma | $48 | 29.4% upside | |
| 2026-05-21 | Craig-HallumAdam Vogel | $43 | 15.9% upside | |
| 2026-05-04 | H.C. WainwrightRaghuram Selvaraju | $45 | 21.3% upside | |
| 2025-11-21 | Leerink PartnersMarc Goodman | $30 | 19.1% downside | |
| 2025-11-21 | JefferiesAndrew Tsai | $32 | 13.7% downside | |
| 2025-11-21 | Stifel Nicolaus | $28 | 24.5% downside | |
| 2025-11-21 | Morgan Stanley | $34 | 8.3% downside | |